UDIBI

Regulatory Pathway for Licensing Biotherapeutics in Mexico. VER MÁS

Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon®). VER MÁS

Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy. VER MÁS

Fecha de publicación: 20 Septiembre 2019 Validation of a Cell Proliferation Assay to Assess the Potency of a Dialyzable...

Fecha de publicación: Septiembre 2019 A differential sex-specific pattern of IgG2 and IgG4 subclasses of anti-drug antibodies (ADAs) induced...

Taking advantage of a high-throughput flow cytometer for the implementation of an ADCC assay for regulatory compliance. VER MÁS

Characterization of a Complex Mixture of Immunomodulator Peptides Obtained from Autologous Urine. VER MÁS

Fecha de publicación: 20 de marzo del 2021 Consistency of a dialyzable leucocyte extract manufactured at GMPfacilities by Nuclear...